Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin vs Fenofibrate in HIV with Low HDL
NCT01426438Phase 2Completed
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in dyslipidemia comparing Niacin + Aspirin with Fenofibrate (2 arms). Primary endpoint: Absolute Change in Relative Flow Mediated Dilation at 24 weeks. Started Nov 2011; status: completed.
02
Drugs
niacinfenofibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01426438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426438.